Skip to main content

Dyslipidemia

Featured Article
Regeneron and Sanofi announced plans to offer the PCSK9 inhibitor, Praluent (alirocumab), at a significantly reduced price starting early March 2019 in an effort to make the drug more available to…
In the second installment of this series, Amit Khera, MD, director of Preventive Cardiology and a Professor of Medicine at UT-Southwestern Medical Center in Dallas, discusses lifestyle risk, long-…

Insights

In the second installment of this series, Amit Khera, MD, director of Preventive Cardiology and a Professor of Medicine at UT-Southwestern Medical Center in Dallas, discusses lifestyle risk, long-term risk, and genetic cholesterol problems among…
Amit Khera, MD, director of Preventive Cardiology and a Professor of Medicine at UT-Southwestern Medical Center in Dallas, explains how patient outcomes impact primary and secondary prevention and related treatment costs.
Back to Top